BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15199750)

  • 1. [Allogeneic peripheral blood stem cell transplantation for a hepatitis B virus carrier with Epstein-Barr virus associated with hemophagocytic syndrome].
    Sakai R; Maruta A; Yamazaki E; Kamijo A; Taguchi J; Hyo R; Tanaka M; Fujimaki K; Nagao T; Yoshiba M; Ishigatsubo Y
    Rinsho Ketsueki; 2004 May; 45(5):397-401. PubMed ID: 15199750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
    Uehara T; Nakaseko C; Hara S; Harima A; Ejiri M; Yokota A; Saito Y; Nishimura M
    Am J Hematol; 2004 Aug; 76(4):368-72. PubMed ID: 15282671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of a long-time survivor with chronic active Epstein-Barr virus infection.
    Takeoka Y; Nakao Y; Ueda M; Koh KR; Aoyama Y; Nakamae H; Yamamura R; Ohta K; Takubo T; Yamane T; Hino M; Tokura Y; Ishihara S; Oshima K; Kimura H; Imashuku S
    Eur J Haematol; 2004 Jan; 72(1):73-6. PubMed ID: 14962269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection.
    Fujii N; Takenaka K; Hiraki A; Maeda Y; Ikeda K; Shinagawa K; Ashiba A; Munemasa M; Sunami K; Hiramatsu Y; Ishimaru F; Niiya K; Yoshino T; Harada M
    Bone Marrow Transplant; 2000 Oct; 26(7):805-8. PubMed ID: 11042666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful umbilical cord blood transplantation from an unrelated donor for a patient with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Minegishi M; Ohashi Y; Kumaki S; Sasahara Y; Hayashi T; Asada H; Okuyama T; Hakozaki I; Sato T; Tsuchiya S
    Bone Marrow Transplant; 2001 Apr; 27(8):883-6. PubMed ID: 11477448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful report of reduced-intensity stem cell transplantation from unrelated umbilical cord blood in a girl with chronic active Epstein-Barr virus infection.
    Iguchi A; Kobayashi R; Sato TZ; Nakajima M; Kaneda M; Ariga T
    J Pediatr Hematol Oncol; 2006 Apr; 28(4):254-6. PubMed ID: 16679925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
    Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
    Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic active Epstein-Barr virus infection treated with reduced intensity stem cell transplantation].
    Sakata N; Sato E; Sawada A; Yasui M; Inoue M; Kawa K
    Rinsho Ketsueki; 2004 May; 45(5):393-6. PubMed ID: 15199749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epstein-Barr virus-associated hemophagocytic syndrome during mid-term pregnancy successfully treated with combined methylprednisolone and intravenous immunoglobulin].
    Mihara H; Kato Y; Tokura Y; Hattori Y; Sato A; Kobayashi H; Imamura A; Daimaru O; Miwa H; Nitta M
    Rinsho Ketsueki; 1999 Dec; 40(12):1258-64. PubMed ID: 10658479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N; Adachi A; Mori T; Kamata H; Nakahara J; Yokoyama K; Yamada T; Kizaki M; Sakamoto M; Ikeda Y; Okamoto S
    Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Imashuku S; Teramura T; Tauchi H; Ishida Y; Otoh Y; Sawada M; Tanaka H; Watanabe A; Tabata Y; Morimoto A; Hibi S; Henter JI
    Haematologica; 2004 Feb; 89(2):183-8. PubMed ID: 15003893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous resolution of hemophagocytic syndrome associated with acute parvovirus B19 infection and concomitant Epstein-Barr virus reactivation in an otherwise healthy adult.
    Larroche C; Scieux C; Honderlick P; Piette AM; Morinet F; Blétry O
    Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):739-42. PubMed ID: 12415473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
    J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus associated post-transplantation lymphoproliferative disorder with hemophagocytosis in a child with Wiskott-Aldrich syndrome.
    Wang IJ; Lu MY; Chiang BL; Lin WC; Lin DT; Lin KH
    Pediatr Blood Cancer; 2005 Sep; 45(3):340-3. PubMed ID: 15547918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature.
    George TI; Jeng M; Berquist W; Cherry AM; Link MP; Arber DA
    Pediatr Blood Cancer; 2005 Mar; 44(3):270-6. PubMed ID: 15468305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E; Cornelissen JJ
    Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virological and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome.
    Sato S; Kawashima H; Oshiro H; Hasegawa D; Kashiwagi Y; Takekuma K; Hoshika A
    J Clin Virol; 2004 Nov; 31(3):235-8. PubMed ID: 15465418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan.
    Imashuku S; Hibi S; Todo S; Sako M; Inoue M; Kawa K; Koike K; Iwai A; Tsuchiya S; Akiyama Y; Kotani T; Kawamura Y; Hirosawa M; Hasegawa D; Kosaka Y; Yamaguchi H; Ishii E; Kato K; Ishii M; Kigasawa H
    Bone Marrow Transplant; 1999 Mar; 23(6):569-72. PubMed ID: 10217187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.